바로가기메뉴

본문 바로가기 주메뉴 바로가기

p16INK4a Promoter Hypermethylation in Sputum, Blood, and Tissue from Non-Small Cell Lung Cancer and Pulmonary Inflammation

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2006, v.60 no.2, pp.160-170









  • Downloaded
  • Viewed

Abstract

Background : The aberrant promoter hypermethylation of p16INK4a, as a tumor suppressor gene, is contributory factor to non-small cell lung cancer(NSCLC). However, its potential diagnostic impact of lung cancer is unclear. This study measured the level of p16INK4a promoter hypermethylation in the sputum and blood, and compared this with the level measured in the tissue obtained from NSCLC and pulmonary inflammation.Methods : Of the patients who visited the Our Lady of Mercy Hospital in Incheon, Korea for an evaluation of a lung mass and underwent blood, sputum, and tissue tests, 23patients (18 NSCLC, 5 pulmonary inflammation) were enrolled in this study. DNA was extracted from each sample and the level of p16INK4amethylation was determined using methylation-specific polymerase chain reaction.Results : p16INK4a methylation of the blood was observed in 88.9% (16 of 18) and 20.0% (1 of 5) of NSCLC and from pulmonary inflammation samples, respectively (P=0.008). Methylation of the sputum was observed in 83.3% (10 of 12) 80.0% (4 of 5) of NSCLC and pulmonary inflammation samples, respectively (P=1.00). Among the 8 NSCLC tissue samples, methylation changes were detected in 75.0% of samples (6 cases). Four out of seven tissue samples (57.1%) showed concordance, being methylated in both the blood and sputum.Conclusions : There was a higher level of p16INK4a methylation of the blood from NSCLC patients than from pulmonary inflammation. The tissue showed a high concordance with the blood in the NSCLC samples. These findings suggest that p16INK4a promoter hypermethylation of the blood can used to discriminate between NSCLC and pulmonary inflammation.(Tuberc Respir Dis 2006; 60: 160-171)

keywords
p16INK4a promoter hypermethylation, Non-small cell lung cancer, Pulmonary inflammation, p16INK4a promoter hypermethylation, Non-small cell lung cancer, Pulmonary inflammation

Reference

1.

(2000) Cancer statistics, 2000,

2.

(2004) 2003년 사망원인통계결과, 통계청

3.

(1989) Screening for lung cancer.Ann Intern Med,

4.

(2002) Long-term results of combined modality therapy in resectable non-small?cell lung cancer,

5.

(1974) Early roentgenographic appearance of bronchogenic carcinoma,

6.

(1966) An evaluation of radiologic and cytologic screening for the early detection of lung cancer a cooperative pilot study of the American Cancer Society and the Veterans Administration,

7.

(1968) South London Lung Cancer Study.Br Med J,

8.

(1968) The value of lung cancer detection by six,

9.

(1989) A 10 year follow-up of semi-annual screening for early detection of lung cancer in the Erfurt County,

10.

(1984) results of the initial radiologic and cytologic screening in the Johns Hopkins study,

11.

(1984) results of the initial radiologic and cytologic screening in the Memorial Sloan-Kettering study,

12.

(1984) results of the initial radiologic and cytologic screening in the Mayo Clinic study,

13.

(1986) Results of a randomized prospective study in Czechoslovakia,

14.

(1999) Molecular pathogenesis of lung cancer.J Thorac Cardiovasc Surg,

15.

(1999) Cancer epigenetics comes of age,

16.

(2001) DNA methylation: an alternative pathway to cancer,

17.

(1999) Hypermethylation of tumor suppressor genes in cancer,

18.

(1994) A cell cycle regulator potentially involved in genesis of many tumor types.Science,

19.

(1994) Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.Oncogene,

20.

(4) Detection of oncogene mutations in sputum precedes diagnosis of lung cancer.Cancer Res,

21.

(1998) Aberrant methylation of p16 is an early event in lung cancer and a potential biomarker for early diagnosis,

22.

(1999) Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients,

23.

(1999) Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer,

24.

(2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum,

25.

(2000) Differential frequencies of p16 and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers,

26.

(2002) Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers,

27.

(2004) alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers,

28.

(1997) Revisions in the International System for Staging Lung Cancer.,

29.

(1977) Analysis of human Y specific reiterated DNA in chromosome variants,

30.

(1996) Methylation?specific PCR: a novel PCR assay for methylation status of CpG islands,

31.

(1991) rational strategies for early detection and intervention,

32.

(1999) Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma,

33.

(1999Apr) Correlation of abnormal RB and p53 expression with 3p loss of heterozygosity and clinical features in 103 primary non-small cell lung cancers,

34.

(1996aug) Rb and p16INK4a expression in resected non?small cell lung tumors,

35.

(1999) DNA methylation.,

36.

(1996) The DNA methylation machinery as a target for anticancer therapy,

37.

(1993) Number of CpG islands and genes in human and mouse.Proc Natl Acad Sci U S A,

38.

(1986) rich islands and the function of DNA methylation,

39.

(1997) Tying it all together: epigenetics, genetics, cell cycle, and cancer,

40.

(1988) Mechanisms of X,

41.

(1997) The (epi)genetic control of mammalian X-chromosome inactivation,

42.

(1999) Gene silencing in the development of cancer.,

43.

(1991) DNA methylation and gene expression.Microbiol Rev,

44.

(1987) Temporal and regional changes in DNA methylation in the embryonic extraembryonic and germ cell lineages during mouse embryo development,

45.

(1996) De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells.,

46.

(1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.Cell,

47.

(1997) DNA methylation and imprinting: why bother?,

48.

(1995) Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation a new model for epigenetic carcinogens,

49.

(1997) Frequent aberrant methylation of p16INK4a in primary rat lung tumors,

50.

The discovery of 5 methyl cytosine in tuberculinic acid the nucleic acid of the tubercle bacillus,

51.

(1948) The quantitative separation of purines,pyrimidines,and nucleotides by paper chromatography,

52.

(1981) Deoxyribonucleic acid methylation in mycobacteria.J Bacteriol,

53.

(1995) DNA methylation in mycobacteria: absence of methylation at GATC (Dam) and CCA/TGG (Dcm) sequences.,

54.

(1998) Cancer statistics,

55.

(1998) Aging and DNA methylation in colorectal mucosa and cancer.,

56.

(1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon.,

57.

(1984) Screening for early lung cancer Results of the Memorial Sloan-Kettering study in New York,

Tuberculosis & Respiratory Diseases